Pharmacy & Biological SciencesCategory
The increasing cost of Type 1 diabetes, one of the most common serious chronic diseases, has created heavy financial burdens for families, with insulin prices more than doubling in the past decade.
Take a look at highlights from 15 years of changes in biopharmaceutical manufacturing.
Only one in four Americans believes the U.S. government’s role in funding research is irreplaceable, according to a study by ScienceCounts.
The FDA established the Patient Engagement Advisory Committee in a move to broaden patient engagement and strengthen patients’ voice in regulatory activities.
The pharmaceutical industry fears major legislation that would curb prices and shrink profits, and has launched campaigns against it—but how honest are their claims?
The National Science Foundation recently issued 27 new grants totaling more than $8 million to promote “diversity and inclusion” in STEM fields.
The recipient’s ultimate goal is to advance nano-bio-manufacturing methods that could lead to large-scale fabrication of functional heart tissue, which could replace diseased or damaged muscle after a heart attack.
The FDA is changing the way it approves medicines known as “orphan drugs” after revelations that drugmakers may be abusing a law intended to help patients with rare diseases.
GSU’s Institute for Biomedical Sciences has welcomed its first class into an innovative interdisciplinary program meant to cultivate the next generation of leaders in the biomedical sector.
The program is a bold effort to gather data over time from more than 1M people living in the U.S., with the ultimate goal of accelerating research and improving health.